Our Team

Leaders in Biopharmaceutical Innovation

Our leadership team is a coalition of disruptors with over 150 years of combined R&D experience and a history of delivering two of the 10 largest biopharma deals of the last century. They are committed to advancing the future of medicine, creating approved medicines, and consistently delivering value to our shareholders.

greg-bailey - Juvenescence

Dr. Greg Bailey

Co-founder, Executive Chairman

jim-mellon - Juvenescence

Jim Mellon

Co-founder, Deputy Chairman

declan-doogan - Juvenescence

Dr. Declan Doogan

Co-founder, Board Member

richard-marshall - Juvenescence

Dr. Richard Marshall

Chief Executive Officer

gill-dines - Juvenescence

Dr. Gillian Dines

Chief Science Officer

steve-delstead - Juvenescence

Dr. Steve Felstead

Chief Medical Officer

David Gill

Chief Financial Officer

jeff-madwed - Juvenescence

Dr. Jeff Madwed

Senior Project Lead

RPerrone_Headsot_01 - Juvenescence

Dr. Rosalba Perrone

Senior Research Scientist

Kersten-Small - Juvenescence

Dr. Kersten Small

Project Leader

Alexander Pickett

Managing Director

fiona - Juvenescence

Fiona McCarrick

General Counsel

Yehudah Nevies

Director Investor Relations

Juvenescence Leadership Instrumental In Development Of Medicines With Peak Annual Sales Of $30bn

NOR_logo_rerelease

flomax_logo

Nucala